Disassociation of Met-Mediated Biological Responses In Vivo: the Natural Hepatocyte Growth Factor/Scatter Factor Splice Variant NK2 Antagonizes Growth but Facilitates Metastasis

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Molecular and Cellular Biology

• Publication date

  2000-03-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1128/MCB.20.6.2055-2065.2000PMID 10688652PMCID PMC110822
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Crystal structure of the NK1 fragment of HGF/SF suggests a novel mode for growth factor dimerization and receptor binding

  1999cited by this paper
• Differential signaling by alternative HGF isoforms through c-Met: activation of both MAP kinase and PI 3-kinase pathways is insufficient for mitogenesis

  1999cited by this paper
• Concomitant activation of pathways downstream of Grb2 and PI 3-kinase is required for MET-mediated metastasis

  1999cited by this paper
• Induction of tissue inhibitor of metalloproteinases-3 is a delayed early cellular response to hepatocyte growth factor

  1998cited by this paper
• Agonistic monoclonal antibodies against the Met receptor dissect the biological responses to HGF.

  1998cited by this paper
• Differential effects of hepatocyte growth factor isoforms on epithelial and endothelial tubulogenesis.

  1998cited by this paper
• Insights into the structure of hepatocyte growth factor/scatter factor (HGF/SF) and implications for receptor activation

  1998cited by this paper
• Trisomy 7-harbouring non-random duplication of the mutant MET allele in hereditary papillary renal carcinomas

  1998cited by this paper
• NK1, a Natural Splice Variant of Hepatocyte Growth Factor/Scatter Factor, Is a Partial Agonist In Vivo

  1998cited by this paper
• c-Met autocrine activation induces development of malignant melanoma and acquisition of the metastatic phenotype.

  1998influential reference
• Crystal structure of the NK1 fragment of human hepatocyte growth factor at 2.0 A resolution.

  1998cited by this paper
• Phosphoinositide 3-Kinase Induces Scattering and Tubulogenesis in Epithelial Cells through a Novel Pathway*

  1998cited by this paper
• Switching signals on or off by receptor dimerization.

  1998cited by this paper
• Renal tubular hyperplasia, polycystic disease, and glomerulosclerosis in transgenic mice overexpressing hepatocyte growth factor/scatter factor.

  1997cited by this paper
• HGF/SF in angiogenesis.

  1997cited by this paper
• Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomas

  1997cited by this paper
• Cdc42 and Rac1 induce integrin-mediated cell motility and invasiveness through PI(3)K

  1997cited by this paper
• HGF/NK4 is a specific antagonist for pleiotrophic actions of hepatocyte growth factor

  1997cited by this paper
• Diverse tumorigenesis associated with aberrant development in mice overexpressing hepatocyte growth factor/scatter factor.

  1997influential reference
• Activation of phosphoinositide 3-OH kinase by the alpha6beta4 integrin promotes carcinoma invasion.

  1997cited by this paper
• A point mutation in the MET oncogene abrogates metastasis without affecting transformation.

  1997cited by this paper
• Activating mutations for the met tyrosine kinase receptor in human cancer.

  1997cited by this paper
• Functional and biophysical characterization of recombinant human hepatocyte growth factor isoforms produced in Escherichia coli.

  1997influential reference
• Hepatocyte growth factor/scatter factor—Met signaling in tumorigenicity and invasion/metastasis

  1996cited by this paper
• Guide for the Care and Use of Laboratory Animals

  1996cited by this paper
• Emerging multipotent aspects of hepatocyte growth factor.

  1996cited by this paper
• Retrogenic expression of the MET proto-oncogene correlates with the invasive phenotype of human rhabdomyosarcomas.

  1996cited by this paper
• Scatter factor/hepatocyte growth factor as a regulator of skeletal muscle and neural crest development.

  1996cited by this paper
• Interaction between Gab1 and the c-Met receptor tyrosine kinase is responsible for epithelial morphogenesis

  1996cited by this paper
• Enhanced tumorigenicity and invasion-metastasis by hepatocyte growth factor/scatter factor-met signalling in human cells concomitant with induction of the urokinase proteolysis network

  1996influential reference
• Autocrine hepatocyte growth factor/scatter factor-Met signaling induces transformation and the invasive/metastastic phenotype in C127 cells.

  1996cited by this paper
• Specific Uncoupling of GRB2 from the Met Receptor

  1996cited by this paper
• Heparin induces dimerization and confers proliferative activity onto the hepatocyte growth factor antagonists NK1 and NK2

  1996influential reference
• Coexpression of hepatocyte growth factor and receptor (Met) in human breast carcinoma.

  1996cited by this paper
• Hepatocyte Growth Factor (HGF)/NK1 Is a Naturally Occurring HGF/Scatter Factor Variant with Partial Agonist/Antagonist Activity*

  1996cited by this paper
• Hepatocyte growth factor/scatter factor overexpression induces growth, abnormal development, and tumor formation in transgenic mouse livers.

  1996cited by this paper
• The many faces of hepatocyte growth factor: from hepatopoiesis to hematopoiesis

  1995cited by this paper
• Met proto-oncogene product is overexpressed in tumors of p53-deficient mice and tumors of Li-Fraumeni patients.

  1995cited by this paper
• Essential role for the c-met receptor in the migration of myogenic precursor cells into the limb bud

  1995cited by this paper
• Scatter factor/hepatocyte growth factor is essential for liver development

  1995cited by this paper
• Placental defect and embryonic lethality in mice lacking hepatocyte growth factor/scatter factor

  1995cited by this paper
• In vivo activation of met tyrosine kinase by heterodimeric hepatocyte growth factor molecule promotes angiogenesis.

  1995cited by this paper
• Mutation of juxtamembrane tyrosine residue 1001 suppresses loss-of-function mutations of the met receptor in epithelial cells.

  1995cited by this paper
• The Met/HGF receptor is over-expressed in human osteosarcomas and is activated by either a paracrine or an autocrine circuit.

  1995cited by this paper
• Hepatocyte Growth Factor-induced Scatter of Madin-Darby Canine Kidney Cells Requires Phosphatidylinositol 3-Kinase (*)

  1995cited by this paper
• Transforming growth factor alpha disrupts the normal program of cellular differentiation in the gastric mucosa of transgenic mice.

  1995cited by this paper
• Creation of an hepatocyte growth factor/scatter factor autocrine loop in carcinoma cells induces invasive properties associated with increased tumorigenicity.

  1994cited by this paper
• The Met proto-oncogene mesenchymal to epithelial cell conversion.

  1994cited by this paper
• Invasiveness and metastasis of NIH 3T3 cells induced by Met-hepatocyte growth factor/scatter factor autocrine stimulation.

  1994cited by this paper
• A multifunctional docking site mediates signaling and transformation by the hepatocyte growth factor/scatter factor receptor family.

  1994cited by this paper
• Distal regulatory elements from the mouse metallothionein locus stimulate gene expression in transgenic mice

  1993cited by this paper
• Scatter factor/hepatocyte growth factor and its receptor, the c-met tyrosine kinase, can mediate a signal exchange between mesenchyme and epithelia during mouse development

  1993cited by this paper
• Met expression and sarcoma tumorigenicity.

  1993cited by this paper
• Generation and characterization of a competitive antagonist of human hepatocyte growth factor, HGF/NK1.

  1993cited by this paper
• A novel recognition motif for phosphatidylinositol 3-kinase binding mediates its association with the hepatocyte growth factor/scatter factor receptor

  1993influential reference
• Hepatocyte growth factor/scatter factor and its receptor, the c-met proto-oncogene product.

  1993cited by this paper
• Tumorigenesis induced by coexpression of human hepatocyte growth factor and the human met protooncogene leads to high levels of expression of the ligand and receptor.

  1993cited by this paper
• Expression of the c-Met/HGF receptor in human melanocytic neoplasms: demonstration of the relationship to malignant melanoma tumour progression.

  1993cited by this paper
• Cloning, sequencing, and expression of human macrophage stimulating protein (MSP, MST1) confirms MSP as a member of the family of kringle proteins and locates the MSP gene on chromosome 3.

  1993cited by this paper
• A functional domain in the heavy chain of scatter factor/hepatocyte growth factor binds the c-Met receptor and induces cell dissociation but not mitogenesis.

  1992influential reference
• Tumorigenicity of the met proto-oncogene and the gene for hepatocyte growth factor

  1992cited by this paper
• Functional characterization of human hepatocyte growth factor mutants obtained by deletion of structural domains.

  1992cited by this paper
• Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product.

  1991cited by this paper
• Characterization of the DNF15S2 locus on human chromosome 3: identification of a gene coding for four kringle domains with homology to hepatocyte growth factor.

  1991cited by this paper
• A broad-spectrum human lung fibroblast-derived mitogen is a variant of hepatocyte growth factor.

  1991cited by this paper
• The receptor encoded by the human C‐MET oncogene is expressed in hepatocytes, epithelial cells and solid tumors

  1991cited by this paper
• Identification of a competitive HGF antagonist encoded by an alternative transcript.

  1991influential reference
• Hepatocyte growth factor--scatter factor: mitogen, motogen, and met.

  1991cited by this paper
• An alternatively processed mRNA generated from human hepatocyte growth factor gene.

  1991cited by this paper
• Hepatocyte growth factor (HGF) stimulates the tyrosine kinase activity of the receptor encoded by the proto-oncogene c-MET.

  1991cited by this paper
• The Structures of Domains of Blood Proteins

  1991cited by this paper
• TGF alpha overexpression in transgenic mice induces liver neoplasia and abnormal development of the mammary gland and pancreas.

  1990influential reference
• Structure, tissue-specific expression, and transforming activity of the mouse met protooncogene.

  1990cited by this paper
• Characterization of the rearranged tpr-met oncogene breakpoint

  1987cited by this paper
• Mechanism of met oncogene activation.

  1986cited by this paper
• Differential Effects of Hepatocyte Growth Factor Isoforms on Epithelial and Endothelial Tubulogenesis1

  year unknowninfluential reference

• Lung Cancer Receptors and Targeting Strategies

  2019cites this paper
• H1/pHGFK1 nanoparticles exert anti-tumoural and radiosensitising effects by inhibition of MET in glioblastoma

  2018cites this paper
• Targeting HGF with Antibodies as an Anti‐Cancer Therapeutic Strategy

  2018cites this paper
• The hepatocyte growth factor isoform NK2 activates motogenesis and survival but not proliferation due to lack of Akt activation.

  2016cites this paper
• Hepatocyte growth factor and alternative splice variants - expression, regulation and implications in osteogenesis and bone health and repair

  2016cites this paper
• Characterization of an oncolytic adenovirus vector constructed to target the cMet receptor

  2015cites this paper
• Expression array analysis of the hepatocyte growth factor invasive program

  2015cites this paper
• Physiological Signaling and Structure of the HGF Receptor MET

  2014cites this paper
• Using genomics for drug discovery in medulloblastoma

  2014cites this paper
• Hepatocyte Growth Factor Isoforms in Tissue Repair, Cancer, and Fibrotic Remodeling

  2014influential citation
• Design and synthesis of 3,3'-biscoumarin-based c-Met inhibitors.

  2014cites this paper
• Defining the functions of alveolar c-Met in late-stage emphysema Committee :

  2014cites this paper
• Targeting tumor micro-environment for design and development of novel anti-angiogenic agents arresting tumor growth.

  2013cites this paper
• Myeloma plasma cell expression of osteoblast regulatory genes: overexpression of SFRP3 correlates with clinical bone involvement at diagnosis

  2013cites this paper
• HGF–MET Cascade, a Key Target for Inhibiting Cancer Metastasis: The Impact of NK4 Discovery on Cancer Biology and Therapeutics

  2013cites this paper
• Structural basis of MET receptor dimerization by the bacterial invasion protein InlB and the HGF/SF splice variant NK1.

  2013cites this paper
• Targeting the HGF-cMET Axis in Hepatocellular Carcinoma

  2013cites this paper
• Hepatocyte growth factor pathway upregulation in the bone marrow microenvironment in multiple myeloma is associated with lytic bone disease

  2013cites this paper
• Discovery of a novel class of exquisitely selective mesenchymal-epithelial transition factor (c-MET) protein kinase inhibitors and identification of the clinical candidate 2-(4-(1-(quinolin-6-ylmethyl)-1H-[1,2,3]triazolo[4,5-b]pyrazin-6-yl)-1H-pyrazol-1-yl)ethanol (PF-04217903) for the treatment of

  2012cites this paper
• Growth factor signaling in metastasis: current understanding and future opportunities

  2012cites this paper
• Targeting MET in cancer: rationale and progress

  2012cites this paper
• Paradoxical action of growth factors: antiproliferative and proapoptotic signaling by HGF/c-MET

  2011influential citation
• The Role of HGF/c-Met Pathway Signaling in Human Medulloblastoma

  2011cites this paper
• Structural basis for agonism and antagonism of hepatocyte growth factor

  2010cites this paper
• Hepatocyte growth factor activators , inhibitors and antagonists and their implication in cancer intervention

  2010cites this paper
• HGF/c-MET Signaling in Advanced Cancers

  2010cites this paper
• MET molecular mechanisms and therapies in lung cancer

  2010cites this paper
• Down-regulation of c-Met expression inhibits human HCC cells growth and invasion by RNA interference.

  2010cites this paper
• Noncoding mutations of HGF are associated with nonsyndromic hearing loss, DFNB39.

  2009cites this paper
• HEPATOCYTE GROWTH FACTOR : ITS ROLE IN HEPATIC GROWTH AND PATHOBIOLOGY

  2009influential citation
• Inhibition of HGF/MET as therapy for malignancy

  2009cites this paper
• Overexpression of NK2 promotes liver fibrosis in carbon tetrachloride‐induced chronic liver injury

  2007cites this paper
• HGF ameliorates a high-fat diet-induced fatty liver.

  2007cites this paper
• A novel small molecule Met inhibitor, PF2362376, exhibits biological activity against osteosarcoma.

  2007cites this paper
• Inhibitors targeting hepatocyte growth factor receptor and their potential therapeutic applications

  2007cites this paper
• Antimalarial drugs – host targets (re)visited

  2006cites this paper
• Identification of Novel Tumor Suppressor Genes for Breast Cancer

  2006cites this paper
• Inhibitors targeting hepatocyte growth factor receptor and vascular endothelial growth factor receptor tyrosine kinases

  2006cites this paper
• Therapeutic targeting of receptor tyrosine kinases in lung cancer

  2005cites this paper
• Overexpression of NK2 inhibits liver regeneration after partial hepatectomy in mice.

  2005cites this paper
• The Interactions of Hepatocyte Growth Factor/Scatter Factor and Its NK1 and NK2 Variants with Glycosaminoglycans Using a Modified Gel Mobility Shift Assay

  2004cites this paper
• Therapeutic targeting of the receptor tyrosine kinase Met.

  2004cites this paper
• Molecular Targeting and Signal Transduction

  2004cites this paper
• Kinase Cells Transformed by the Oncogenic TPR-MET Tyrosine A Novel Small Molecule Met Inhibitor Induces Apoptosis in Updated

  2003cites this paper
• A novel small molecule met inhibitor induces apoptosis in cells transformed by the oncogenic TPR-MET tyrosine kinase.

  2003cites this paper
• The N-terminal Domain of Hepatocyte Growth Factor Inhibits the Angiogenic Behavior of Endothelial Cells Independently from Binding to the c-met Receptor*

  2003cites this paper
• Hepatocyte growth factor/scatter factor induces feedback up-regulation of CD44v6 in melanoma cells through Egr-1.

  2003cites this paper
• Roles of hepatocyte growth factor (HGF) activator and HGF activator inhibitor in the pericellular activation of HGF/scatter factor

  2003cites this paper
• Human Adult Chondrocytes Express Hepatocyte Growth Factor (HGF) Isoforms but Not HGF: Potential Implication of Osteoblasts on the Presence of HGF in Cartilage

  2003influential citation
• c-Met: Structure, functions and potential for therapeutic inhibition

  2003cites this paper
• Immunohistochemical Localization of Hepatocyte Growth Factor Activator (HGFA) in Developing Mouse Liver Tissues: Heterogeneous Distribution of HGFA Protein

  2003cites this paper
• Pulmonary dendritic cell trafficking in health and disease

  2003cites this paper
• Lifetime exposure to a soluble TGF-β antagonist protects mice against metastasis without adverse side effects

  2002cites this paper
• Up-Regulation of CD 44 v 6 in Melanoma Cells through Egr-1 Hepatocyte Growth Factor / Scatter Factor Induces Feedback

  2002cites this paper
• Role of the hepatocyte growth factor receptor, c-Met, in oncogenesis and potential for therapeutic inhibition.

  2002cites this paper
• Constitutive c-Met signaling through a nonautocrine mechanism promotes metastasis in a transgenic transplantation model.

  2002influential citation
• The role of hepatocyte growth factor (scatter factor) in epithelial-mesenchymal transition and breast cancer.

  2002cites this paper
• CCl4‐induced acute liver injury in mice is inhibited by hepatocyte growth factor overexpression but stimulated by NK2 overexpression

  2002cites this paper
• [Molecular mechanism regulating activation of hepatocyte growth factor].

  2001cites this paper
• SF/HGF-c-Met autocrine and paracrine promote metastasis of hepatocellular carcinoma.

  2001cites this paper
• Hepatocyte growth factor expression in human cancer and therapy with specific inhibitors.

  2001cites this paper
• Hepatocyte growth factor activators, inhibitors and antagonists and their implication in cancer intervention.

  2001cites this paper
• Accelerated ultraviolet radiation-induced carcinogenesis in hepatocyte growth factor/scatter factor transgenic mice.

  2000cites this paper
• Mechanism of regulation of HGF/SF gene expression in fibroblasts by TGF-beta1.

  2000cites this paper
• Glioma inhibition by HGF/NK2, an antagonist of scatter factor/hepatocyte growth factor.

  2000cites this paper
• Ligand discrimination by ErbB receptors: differential signaling through differential phosphorylation site usage

  2000influential citation